Skip to content

CVRx, Inc. CVRX Total Equity

Total Equity at other companies

Abbott logo
AbbottABT
$52.06B+6.7%
Boston Scientific logo
Boston ScientificBSX
$25.86B+16.4%
Medtronic logo
MedtronicMDT
$49.46B+3.0%
Neuropace, Inc. logo
Neuropace, Inc.NPCE
$14.45M-40.4%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$435.19M-5.0%
Inspire Medical Systems logo
Inspire Medical SystemsINSP
$792.34M+24.6%

Other financials

Income statement

See full
Revenue$14.8M+19.6%
Gross profit$12.9M+24.9%
Operating income-$12.2M+9.5%
Net income-$13.1M+4.7%
EPS (diluted)-$0.50+5.7%

Balance sheet

See full
Cash & equivalents$72.3M-29.6%
Total debt$59.4M+17.8%
Total assets$99.7M-23.0%

Cash flow

See full
Operating cash flow-$12.2M+4.7%
CapEx$122.0K+7.0%
Free cash flow-$12.3M+4.6%

Valuation

See full
Market cap$148.6M-2.9%
Enterprise value$135.69M+25.0%
P/S2.5×-0.3×

Profitability

See full
Gross margin86.2%+2.7pp
Operating margin-84.6%-8.9pp
Net margin-89.1%-7.0pp
FCF margin-68%-8.1pp

Returns & leverage

See full
Return on equity-107%+73.4pp
Debt / equity+1.3×
Current ratio10.2×-4.6×

Where this comes from

Reported directly by CVRx, Inc. in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: CVRx, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about CVRx, Inc.'s total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CVRx, Inc.'s total equity?
CVRx, Inc. (CVRX) reported total equity of $29.11M in Q1 2026.
How has CVRx, Inc.'s total equity changed year-over-year?
CVRx, Inc.'s total equity decreased by 58.0% year-over-year, from $69.36M to $29.11M.
What is the long-term trend for CVRx, Inc.'s total equity?
Over 5 years (2020 to 2025), CVRx, Inc.'s total equity has grown at a -33.1% compound annual growth rate (CAGR), from -$293.24M to $39.32M.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.